A phase I trial of caffeine to evaluate safety in infants with hypoxic-ischemic encephalopathy.

Jackson, Wesley; Gonzalez, Daniel; Greenberg, Rachel G; Lee, Yueh Z; Laughon, Matthew M

Jackson, Wesley; Gonzalez, Daniel; Greenberg, Rachel G; Lee, Yueh Z; Laughon, Matthew M.

Afiliação

Jackson W; Department of Pediatrics, School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. wesley.jackson@unc.edu.
Gonzalez D; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Greenberg RG; Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA.
Lee YZ; Duke Clinical Research Institute, Durham, NC, USA.
Laughon MM; Department of Radiology, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

J Perinatol ; 44(4): 508-512, 2024 Apr.

Article em En | MEDLINE | ID: mdl-37587184

Assuntos

Hipotermia Induzida; Hipóxia-Isquemia Encefálica; Lactente; Humanos; Cafeína/efeitos adversos; Hipóxia-Isquemia Encefálica/terapia; Hipóxia-Isquemia Encefálica/etiologia; Neuroproteção; Hipotermia Induzida/efeitos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipóxia-Isquemia Encefálica / Hipotermia Induzida Limite: Humans / Infant Idioma: En Revista: J Perinatol Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google